Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 2/3 1

Status

Completed 6Terminated 5Recruiting 4Not yet recruiting 3Active not recruiting 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 6Breast 4CNS 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Endometrial Neoplasms 6Endometrial Hyperplasia 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Megestrol Acetate × Gynecologic × Clear all
NCT04491643 2025-08-11

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

Fudan University

Phase 2 Completed
48 enrolled
Gynecologic

Endometrial Neoplasms

NCT03241914 2020-11-20

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer

Fudan University

Phase 2/3 Completed
64 enrolled
Gynecologic

Endometrial Neoplasms

NCT00729586 2019-07-23

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
73 enrolled 13 charts
Gynecologic

Endometrial Neoplasms

NCT00910091 2019-01-30

The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer

Ipsen

Phase 2 Completed
73 enrolled 19 charts
Gynecologic

Endometrial Neoplasms

NCT00483327 2018-04-04

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

NYU Langone Health

Phase 2 Completed
31 enrolled 9 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT00739830 2015-07-01

Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)

Merck Sharp & Dohme LLC

Phase 2 Completed
130 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡